The FDA has approved Philips' whole body scanning system that uses both PET, or positron emission tomography, and MRI, to detect cancer, according to a Washington Post report.
PET identifies cancer cells as they absorb chemical tracers, and MRI views the surrounding tissue. Philips spokesman Steve Klink compared the PET to a GPS system and MRI to the map.
Related Articles on Medical Devices:
FDA Approves New Boston Scientific Heart Stent
Doctors Question the Value of Robot-Assisted Surgery
FDA's Dr. Jeffrey Shuren Speaks to Congress About Medical Device Approval
PET identifies cancer cells as they absorb chemical tracers, and MRI views the surrounding tissue. Philips spokesman Steve Klink compared the PET to a GPS system and MRI to the map.
Related Articles on Medical Devices:
FDA Approves New Boston Scientific Heart Stent
Doctors Question the Value of Robot-Assisted Surgery
FDA's Dr. Jeffrey Shuren Speaks to Congress About Medical Device Approval